Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06395051
Other study ID # METC24-008
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2024
Est. completion date March 31, 2025

Study information

Verified date April 2024
Source Maastricht University Medical Center
Contact Kevin MR Nijssen
Phone +31433881305
Email k.nijssen@maastrichtuniversity.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Disturbances in brain insulin-sensitivity are not only observed in obesity and type 2 diabetes (T2D), but also during brain aging and in dementia. Ketone monoester supplements may improve brain insulin-sensitivity, which can be quantified by measuring the gray-matter cerebral blood flow (CBF) response to intranasally administered insulin. We hypothesize that acute ketone monoester supplementation increases (regional) brain vascular function and insulin-sensitivity thereby improving cognitive performance and appetite control. The primary objective is to evaluate in older men the acute effect of ketone monoester supplementation on (regional) brain vascular function and insulin-sensitivity, as quantified by the non-invasive gold standard magnetic resonance imaging (MRI)-perfusion method Arterial Spin Labelling (ASL). The CBF response to intranasal insulin is a robust and sensitive physiological marker of brain insulin-sensitivity. Secondary objectives are to investigate effects on cognitive performance as assessed with a neuropsychological test battery, and appetite control as quantified by functional MRI (fMRI) with visual food cues.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 18
Est. completion date March 31, 2025
Est. primary completion date March 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 60 Years to 75 Years
Eligibility Inclusion Criteria: - Men, aged between 60-75 years - BMI between 25-30 kg/m2 - Fasting plasma glucose < 7.0 mmol/L - Fasting serum TC < 8.0 mmol/L - Fasting serum TAG < 4.5 mmol/L - Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg - Stable body weight (weight gain or loss < 3 kg in the past three months) - Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study - No difficult venipuncture as evidenced during the screening visit Exclusion Criteria: - Women - Left-handedness - Following a low-carbohydrate diet or consuming nutritional ketone supplements - Current smoker, or smoking cessation < 12 months - Diabetic patients - Familial hypercholesterolemia - Abuse of drugs - More than 3 alcoholic consumptions per day - Use of products or dietary supplements known to interfere with the main outcomes as judged by the principal investigators - Use medication to treat blood pressure, lipid or glucose metabolism, or neurological or mental disorders. - Use of an investigational product within another biomedical intervention trial within the previous 1-month - Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis - Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident - Contra-indications for MRI imaging (e.g. pacemaker, surgical clips/material in body, metal splinter in eye, claustrophobia).

Study Design


Intervention

Dietary Supplement:
Ketone Monoester
Ketone monoester supplement (395 mg/kg body mass)
Placebo
The placebo will be taste-matched to the active supplement for bitterness using denatonium benzoate and volume-matched with water

Locations

Country Name City State
Netherlands Maastricht University Medical Center Maastricht Limburg

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Brain Vascular Function Cerebral blood flow as quantified non-invasively by the MRI perfusion method Arterial Spin Labeling (ASL) Change from placebo intervention at 30 minutes after supplement intake
Primary Brain Insulin Sensitivity Cerebral blood flow measurements before and after a nasal insulin spray as quantified non-invasively by the MRI perfusion method Arterial Spin Labeling (ASL) Change from placebo intervention at 60 minutes after supplement intake
Secondary Appetite-related brain reward activity Blood oxygenation level-dependent (BOLD)-functional MRI (fMRI) response to food cues Change from placebo intervention at 40 minutes after supplement intake
Secondary Cognitive Performance Cambridge Neuropsychological Test Automated Battery (CANTAB) Change from placebo intervention at 120 minutes after supplement intake
Secondary Brain Perfusion Transcranial Doppler (TCD) ultrasound will be used to assess the velocity of blood flow through the middle cerebral artery (MCA) Change from placebo intervention at 120 minutes after supplement intake
Secondary Blood pressure Office blood pressure and heart rate Change from placebo intervention at 90 minutes after supplement intake
Secondary Ketone metabolism Circulating beta-hydroxybutyrate concentrations During 120 minutes following supplement intake
Secondary Glucose metabolism Circulating glucose and insulin concentrations During 120 minutes following supplement intake
Secondary Markers related to low-grade systemic inflammation Circulating high-sensitive C-reactive protein concentrations During 120 minutes following supplement intake
Secondary Appetite hormones Circulating ghrelin concentrations During 120 minutes following supplement intake
Secondary Perceived hunger and satiety Visual analogue scale (VAS) questionnaires During 120 minutes following supplement intake
Secondary Anthropometric measurements Weight, length, waist and hip circumference Before supplement intake
Secondary Food intake Food Frequency Questionnaire to assess food intake over the past month Once 120 minutes following supplement intake
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04121728 - Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba N/A
Active, not recruiting NCT03516734 - Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh N/A
Not yet recruiting NCT05428228 - Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults N/A
Completed NCT05073406 - Cognition at Altitude in HEMS - Part II N/A
Completed NCT05498129 - School Feeding to Improve Cognitive Performance in Disadvantaged Children N/A
Completed NCT05226039 - The Effects of a Single Bout of Aerobic Exercise on Cognition: The Moderating Role of Age N/A
Completed NCT03169283 - Investigation of How Morning Nutrition Influences Cognitive Performance N/A
Completed NCT01794351 - Cognitive Effects of 500mg Trans-resveratrol N/A
Completed NCT02051153 - Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls N/A
Completed NCT00607204 - Examining the Biological Factors That Affect Sleep Duration N/A
Terminated NCT04056650 - Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers Phase 4
Recruiting NCT05481424 - Evaluating the Potentials of Biodynamic Lighting for Home Office Workers N/A
Completed NCT05281146 - Production of Fortified Biscuit With Chickpea and Crushed Peanut for Improving Cognitive Performance N/A
Completed NCT00395668 - TETRA (Terrestrial Trunked Radio) Phase 4
Active, not recruiting NCT03771716 - Rhythm Experience and Africana Culture Trial N/A
Active, not recruiting NCT03567343 - Investigational Test of a New Sleep Supplement N/A
Completed NCT05032729 - Nutritional Intervention to Enhance Sleep Quality and Quantity in Athletes N/A
Completed NCT04676542 - The Effects of Externally Paced Exercise on Cognitive Performance and Stress in College Aged Students N/A
Not yet recruiting NCT05904431 - The Effect of Cognitive Performance on Physical Performance in Adolescent Basketball Players
Completed NCT04974606 - Effect of Coffeeberry on Mood, Motivation and Cognitive Performance N/A